Tajinder (TP) Singh

Publications

1. Early Renal Failure After Primary Thoracic Organ Transplantation. J Heart Lung Transplant. 2025 Jan 24. View Abstract
2. Socioeconomic Status and Major Adverse Transplant Events in Pediatric Heart Transplant Recipients. JAMA Netw Open. 2024 Oct 01; 7(10):e2437255. View Abstract
3. Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial. Circulation. 2024 Nov 26; 150(22):1756-1766. View Abstract
4. Exercise testing in clinical context: Reference ranges for interpreting anaerobic threshold as an outcome for congenital heart disease patients. Int J Cardiol Congenit Heart Dis. 2024 Dec; 18:100540. View Abstract
5. Impact of a positive crossmatch on pediatric heart transplant outcomes. J Heart Lung Transplant. 2024 Jun; 43(6):963-972. View Abstract
6. Mortality and Heart Transplantation After Hybrid Palliation of Hypoplastic Left Heart Syndrome: A Systematic Review and Meta-Analysis. World J Pediatr Congenit Heart Surg. 2024 Mar; 15(2):215-223. View Abstract
7. Corrigendum to 'The role of sensitization in post-transplant outcomes in adults with congenital heart disease sensitization in adults with congenital heart disease', Int. J. Cardiol. Congenit. Heart Dis., 8, June 2022, 100384. Int J Cardiol Congenit Heart Dis. 2023 Dec; 14:100474. View Abstract
8. Medium-term Outcomes in Pediatric Heart Transplant Recipients Managed Using a Steroid Avoidance Immune Suppression Protocol. Transplantation. 2024 Jan 01; 108(1):e8-e14. View Abstract
9. Impact of donor-specific anti-HLA antibody on cardiac hemodynamics and graft function 3 years after pediatric heart transplantation: First results from the CTOTC-09 multi-institutional study. Am J Transplant. 2023 12; 23(12):1893-1907. View Abstract
10. Graft survival in primary thoracic organ transplant recipients: A special report from the International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2023 10; 42(10):1321-1333. View Abstract
11. Propensity Score Methods for Analyzing Registry Data in Transplant Recipients. Transplantation. 2024 Jan 01; 108(1):12-13. View Abstract
12. Racial and socioeconomic disparities in pediatric heart transplant outcomes in the era of anti-thymocyte globulin induction. J Heart Lung Transplant. 2022 12; 41(12):1773-1780. View Abstract
13. Pediatric heart transplant using hearts from oversized donors. J Heart Lung Transplant. 2022 12; 41(12):1858. View Abstract
14. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-ninth adult lung transplantation report-2022; focus on lung transplant recipients with chronic obstructive pulmonary disease. J Heart Lung Transplant. 2022 10; 41(10):1335-1347. View Abstract
15. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth pediatric lung transplantation report - 2022; focus on pulmonary vascular diseases. J Heart Lung Transplant. 2022 10; 41(10):1348-1356. View Abstract
16. The International thoracic organ transplant registry of the international society for heart and lung transplantation: Twenty-fifth pediatric heart transplantation report-2022; focus on infant heart transplantation. J Heart Lung Transplant. 2022 10; 41(10):1357-1365. View Abstract
17. The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease. J Heart Lung Transplant. 2022 10; 41(10):1366-1375. View Abstract
18. Prognostic Value of Exercise Stress Echocardiography in Pediatric Cardiac Transplant Recipients. J Am Soc Echocardiogr. 2022 11; 35(11):1133-1138.e2. View Abstract
19. The role of sensitization in post-transplant outcomes in adults with congenital heart disease sensitization in adults with congenital heart disease. Int J Cardiol Congenit Heart Dis. 2022 Jun; 8:100384. View Abstract
20. Presentation and outcomes of post-transplant lymphoproliferative disorder at a single institution pediatric transplant center. Pediatr Transplant. 2022 08; 26(5):e14268. View Abstract
21. Matching Donor and Recipient Size in Pediatric Heart Transplantation. Transpl Int. 2022; 35:10226. View Abstract
22. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric heart transplantation report - 2021; focus on recipient characteristics. J Heart Lung Transplant. 2021 10; 40(10):1050-1059. View Abstract
23. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021 10; 40(10):1060-1072. View Abstract
24. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report - 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021 10; 40(10):1035-1049. View Abstract
25. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric lung transplantation report - 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021 10; 40(10):1023-1034. View Abstract
26. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant. J Am Heart Assoc. 2021 07 06; 10(13):e021082. View Abstract
27. Characteristics Associated With High-Performing Pediatric Heart Transplant Centers in the United States From 2006 to 2015. JAMA Netw Open. 2020 11 02; 3(11):e2023515. View Abstract
28. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report - 2020; focus on deceased donor characteristics. J Heart Lung Transplant. 2020 10; 39(10):1016-1027. View Abstract
29. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 23rd pediatric heart transplantation report-2020; focus on deceased donor characteristics. J Heart Lung Transplant. 2020 10; 39(10):1028-1037. View Abstract
30. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics. J Heart Lung Transplant. 2020 10; 39(10):1003-1015. View Abstract
31. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-third pediatric lung transplantation report - 2020; focus on deceased donor characteristics. J Heart Lung Transplant. 2020 10; 39(10):1038-1049. View Abstract
32. Comparison of tissue Doppler imaging and conventional echocardiography to discriminate rejection from non-rejection after pediatric heart transplantation. Pediatr Transplant. 2020 08; 24(5):e13738. View Abstract
33. The re-occurrence of cardiomyopathy in propionic acidemia after liver transplantation. JIMD Rep. 2020 Jul; 54(1):3-8. View Abstract
34. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Transplantation. 2020 01; 104(1):e31-e37. View Abstract
35. Long-Term Survival After Heart Transplantation at Centers Stratified by Short-Term Performance. Circ Heart Fail. 2019 11; 12(11):e005914. View Abstract
36. Black race and outcomes in children with a heart transplant. J Heart Lung Transplant. 2019 12; 38(12):1323-1324. View Abstract
37. Hospital readmission following pediatric heart transplantation. Pediatr Transplant. 2019 11; 23(7):e13561. View Abstract
38. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report - 2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019 10; 38(10):1028-1041. View Abstract
39. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019 10; 38(10):1056-1066. View Abstract
40. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019 10; 38(10):1042-1055. View Abstract
41. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric lung and heart-lung transplantation report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019 10; 38(10):1015-1027. View Abstract
42. Is Doppler echocardiography useful for estimating left ventricular filling pressures in pediatric heart transplant recipients? Pediatr Transplant. 2019 11; 23(7):e13543. View Abstract
43. Extracorporeal membrane oxygenation use in the first 24 hours following pediatric heart transplantation: Incidence, risk factors, and outcomes. Pediatr Transplant. 2019 06; 23(4):e13414. View Abstract
44. Risk factors for death or heart transplantation in single-ventricle physiology (tricuspid atresia, pulmonary atresia, and heterotaxy): A systematic review and meta-analysis. J Heart Lung Transplant. 2019 07; 38(7):739-747. View Abstract
45. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients. J Heart Lung Transplant. 2019 06; 38(6):601-608. View Abstract
46. Reply to the letter: "Center effect on posttransplant survival among currently active United States pediatric heart transplant centers". Am J Transplant. 2018 12; 18(12):3080. View Abstract
47. Center effect on posttransplant survival among currently active United States pediatric heart transplant centers. Am J Transplant. 2018 12; 18(12):2914-2923. View Abstract
48. Are we any nearer to clinically useful pretransplant prediction of post-transplant outcomes? Pediatr Transplant. 2018 05; 22(3):e13157. View Abstract
49. Liver abnormalities and post-transplant survival in pediatric Fontan patients. Pediatr Transplant. 2017 Dec; 21(8). View Abstract
50. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? Circ Heart Fail. 2016 Jan; 9(1):e002328. View Abstract
51. Predicting graft loss by 1 year in pediatric heart transplantation candidates: an analysis of the Pediatric Heart Transplant Study database. Circulation. 2015 Mar 10; 131(10):890-8. View Abstract
52. Risk stratification for in-hospital mortality after heart transplantation using the modification of diet in renal disease and the chronic kidney disease epidemiology collaboration equations for estimated glomerular filtration rate. Transplantation. 2014 Nov 15; 98(9):1000-6. View Abstract
53. Association of hemodynamic profiles with wait-list mortality in children listed for heart transplantation with idiopathic dilated cardiomyopathy. Am J Cardiol. 2015 Jan 15; 115(2):243-8. View Abstract
54. Does the UNOS heart transplant allocation system favor men over women? JACC Heart Fail. 2014 Aug; 2(4):347-55. View Abstract
55. Risk factors and outcome of Fontan-associated plastic bronchitis: a case-control study. J Am Heart Assoc. 2014 Apr 22; 3(2):e000865. View Abstract
56. Survival benefit from transplantation in patients listed for heart transplantation in the United States. J Am Coll Cardiol. 2014 Apr 01; 63(12):1169-1178. View Abstract
57. Survival in patients removed from the heart transplant waiting list before receiving a transplant. J Heart Lung Transplant. 2014 Mar; 33(3):261-9. View Abstract
58. Letter by Singh Regarding Article, "Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children". Circulation. 2013 Nov 12; 128(20):e405. View Abstract
59. Tissue Doppler imaging for rejection surveillance in pediatric heart transplant recipients. J Heart Lung Transplant. 2013 Oct; 32(10):1027-33. View Abstract
60. Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients. Pediatr Transplant. 2013 Nov; 17(7):661-9. View Abstract
61. Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A. J Heart Lung Transplant. 2013 Sep; 32(9):881-8. View Abstract
62. Risk stratification and transplant benefit in children listed for heart transplant in the United States. Circ Heart Fail. 2013 Jul; 6(4):800-8. View Abstract
63. Prognostic value of exercise testing during heart transplant evaluation in children. Circ Heart Fail. 2013 Jul; 6(4):792-9. View Abstract
64. Prospective trial of a pediatric ventricular assist device. N Engl J Med. 2012 11 29; 367(22):2159; author reply 2160-1. View Abstract
65. Cardiac allograft function during the first year after transplantation in rejection-free children and young adults. Circ Cardiovasc Imaging. 2012 Nov; 5(6):756-64. View Abstract
66. Current outcomes in US children with cardiomyopathy listed for heart transplantation. Circ Heart Fail. 2012 Sep 01; 5(5):594-601. View Abstract
67. Racial and ethnic differences in wait-list outcomes in patients listed for heart transplantation in the United States. Circulation. 2012 Jun 19; 125(24):3022-30. View Abstract
68. Letter by Singh regarding article, "Peak oxygen uptake correlates with survival without clinical deterioration in ambulatory children with dilated cardiomyopathy". Circulation. 2012 May 01; 125(17):e634; author reply e635. View Abstract
69. Risk prediction for early in-hospital mortality following heart transplantation in the United States. Circ Heart Fail. 2012 Mar 01; 5(2):259-66. View Abstract
70. A risk-prediction model for in-hospital mortality after heart transplantation in US children. Am J Transplant. 2012 May; 12(5):1240-8. View Abstract
71. Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts. Circ Heart Fail. 2012 Mar 01; 5(2):249-58. View Abstract
72. Pediatric heart failure and worsening renal function: association with outcomes after heart transplantation. J Heart Lung Transplant. 2012 Mar; 31(3):252-8. View Abstract
73. Trends in wait-list mortality in children listed for heart transplantation in the United States: era effect across racial/ethnic groups. Am J Transplant. 2011 Dec; 11(12):2692-9. View Abstract
74. Association of graft ischemic time with survival after heart transplant among children in the United States. J Heart Lung Transplant. 2011 Nov; 30(11):1244-9. View Abstract
75. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States: analysis of data from the Organ Procurement and Transplant Network and Extracorporeal Life Support Organization Registry. Circulation. 2011 Jun 28; 123(25):2975-84. View Abstract
76. Recovery of oxygen consumption after maximal exercise in children. Med Sci Sports Exerc. 2011 Apr; 43(4):555-9. View Abstract
77. Letter by Singh regarding article, "Enalapril in infants with single ventricle: results of a multicenter randomized trial". Circulation. 2011 Mar 15; 123(10):e374. View Abstract
78. Factors associated with in-hospital mortality in infants undergoing heart transplantation in the United States. J Thorac Cardiovasc Surg. 2011 Feb; 141(2):531-6, 536.e1. View Abstract
79. Improved survival in heart transplant recipients in the United States: racial differences in era effect. Circ Heart Fail. 2011 Mar; 4(2):153-60. View Abstract
80. Improved survival in pediatric heart transplant recipients: have white, black and Hispanic children benefited equally? Am J Transplant. 2011 Jan; 11(1):120-8. View Abstract
81. Association of race and socioeconomic position with outcomes in pediatric heart transplant recipients. Am J Transplant. 2010 Sep; 10(9):2116-23. View Abstract
82. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure? J Am Coll Cardiol. 2010 Aug 31; 56(10):823; author reply 823-4. View Abstract
83. Outcomes of heart transplantation using donor hearts from infants with sudden infant death syndrome. J Heart Lung Transplant. 2010 Nov; 29(11):1226-30. View Abstract
84. Coronary diameter and vasodilator function in children following arterial switch operation for complete transposition of the great arteries. Am J Cardiol. 2010 Aug 01; 106(3):421-5. View Abstract
85. Socioeconomic position and heart rate recovery after maximal exercise in children. Arch Pediatr Adolesc Med. 2010 May; 164(5):479-84. View Abstract
86. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis. Circulation. 2010 May 04; 121(17):1926-33. View Abstract
87. Socioeconomic position, ethnicity, and outcomes in heart transplant recipients. Am J Cardiol. 2010 Apr 01; 105(7):1024-9. View Abstract
88. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients. J Heart Lung Transplant. 2010 May; 29(5):517-22. View Abstract
89. Racial and ethnic differences in mortality in children awaiting heart transplant in the United States. Am J Transplant. 2009 Dec; 9(12):2808-15. View Abstract
90. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy. Circ Heart Fail. 2009 Nov; 2(6):591-8. View Abstract
91. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant. 2009 Dec; 28(12):1292-8. View Abstract
92. Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients. J Heart Lung Transplant. 2009 Dec; 28(12):1285-91. View Abstract
93. Association of socioeconomic position and medical insurance with fetal diagnosis of critical congenital heart disease. Circ Cardiovasc Qual Outcomes. 2009 Jul; 2(4):354-60. View Abstract
94. Socioeconomic position and graft failure in pediatric heart transplant recipients. Circ Heart Fail. 2009 May; 2(3):160-5. View Abstract
95. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009 Feb 10; 119(5):717-727. View Abstract
96. Determinants of heart rate recovery following exercise in children. Med Sci Sports Exerc. 2008 Apr; 40(4):601-5. View Abstract
97. Longitudinal changes in heart rate recovery after maximal exercise in pediatric heart transplant recipients: evidence of autonomic re-innervation? J Heart Lung Transplant. 2007 Dec; 26(12):1306-12. View Abstract
98. Longitudinal changes in heart rate-corrected measures of exercise performance in children. Pediatr Cardiol. 2008 Jan; 29(1):60-4. View Abstract
99. Cardiac rehabilitation improves heart rate recovery following peak exercise in children with repaired congenital heart disease. Pediatr Cardiol. 2007 Jul-Aug; 28(4):276-9. View Abstract
100. Clinical trials of newly developed anti-cancer agents in children with acute leukemia. Contemp Clin Trials. 2006 Dec; 27(6):493. View Abstract
101. Hyperlipidemia in children after heart transplantation. J Heart Lung Transplant. 2006 Oct; 25(10):1199-205. View Abstract
102. Association of parental pretransplant psychosocial assessment with post-transplant morbidity in pediatric heart transplant recipients. Pediatr Transplant. 2006 Aug; 10(5):602-7. View Abstract
103. Neonatal heart transplantation to a physiologic single lung. J Heart Lung Transplant. 2006 Mar; 25(3):362-4. View Abstract
104. Severe neutropenia and thrombocytopenia following cardiac transplantation in a child. Pediatr Transplant. 2005 Feb; 9(1):94-6. View Abstract
105. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant. 2004 Dec; 23(12):1313-33. View Abstract
106. Sildenafil for pulmonary hypertension after heart transplantation. J Heart Lung Transplant. 2004 Dec; 23(12):1441-4. View Abstract
107. Transthoracic echocardiography for precardioversion screening during atrial flutter/fibrillation in young patients. Clin Cardiol. 2004 Jul; 27(7):413-6. View Abstract
108. Total lymphoid irradiation: new therapeutic option for refractory giant cell myocarditis. J Heart Lung Transplant. 2004 Apr; 23(4):492-5. View Abstract
109. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant. 2004 Feb; 23(2):178-85. View Abstract
110. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 2003 Feb 19; 41(4):661-5. View Abstract
111. Timing of heart transplantation after a recent pulmonary embolism. J Heart Lung Transplant. 2003 Jan; 22(1):98-101. View Abstract
112. Positron emission tomography myocardial perfusion imaging in children with suspected coronary abnormalities. Pediatr Cardiol. 2003 Mar-Apr; 24(2):138-44. View Abstract
113. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy. Pediatr Cardiol. 2002 Jan-Feb; 23(1):100-2. View Abstract
114. Myocardial flow reserve in patients with a systemic right ventricle after atrial switch repair. J Am Coll Cardiol. 2001 Jun 15; 37(8):2120-5. View Abstract
115. Assessment of progressive changes in exercise performance in patients with a systemic right ventricle following the atrial switch repair. Pediatr Cardiol. 2001 May-Jun; 22(3):210-4. View Abstract
116. Assessment of skeletal muscle ventricle tissue blood flow using positron emission tomography. Artif Organs. 2001 Apr; 25(4):306-12. View Abstract
117. Myocardial blood flow, function, and metabolism in repetitive stunning. J Nucl Med. 2000 Jul; 41(7):1227-34. View Abstract
118. Safety and efficacy of intravenous adenosine for pharmacologic stress testing in children with aortic valve disease or Kawasaki disease. Am J Cardiol. 1999 Jan 15; 83(2):284-6, A6. View Abstract
119. Myocardial flow reserve in long-term survivors of repair of anomalous left coronary artery from pulmonary artery. J Am Coll Cardiol. 1998 Feb; 31(2):437-43. View Abstract
120. Coil occlusion versus conventional surgical closure of patent ductus arteriosus. Am J Cardiol. 1997 May 01; 79(9):1283-5. View Abstract
121. Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography. J Am Coll Cardiol. 1996 Sep; 28(3):757-62. View Abstract
122. Pediatric hypertension: clinical profile and etiology. Indian Pediatr. 1991 Feb; 28(2):141-6. View Abstract
Show All Publications Show Fewer Publications